If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
560.00    1.50 (0.27%)
Bid:
559.50
Ask:
560.00
Spread: 0.50 (0.089%)
Market Cap: £2.48b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

5 Oct 2018 14:05

Tate & Lyle PLC

Notification of transaction by Person Discharging Managerial Responsibilities

Tate & Lyle PLC (the ‘Company’) announces that on 4 October 2018 the following transactions occurred by Nick Hampton, a Person Discharging Managerial Responsibilities (“PDMR”) in respect of his interests in ordinary shares of 25 pence each in the capital of the Company (‘Shares’) under the Tate & Lyle Group Bonus Plan (‘GBP’) and the 2012 Performance Share Plan (‘PSP’).

Following the withholding of Shares to satisfy certain tax obligations arising on the release of Shares, Mr. Hampton’s interests in Shares changed as detailed in the table below:

No. of Shares acquired under the GBP No. of Shares acquired under the PSP
15,565 127,863

For tax purposes, the market value of the Shares, being the close price on the date of the transaction, was 666.4 pence per Share.

No consideration was paid for the acquisition of these Shares.

The GBP was awarded in 2016 and was subject to the satisfaction of employment conditions. Details of the operation of the GBP are contained within the Annual Report 2016.

Awards made under the PSP are subject to the satisfaction of performance conditions over a three year performance period, which in this case ran from 1 April 2015 to 31 March 2018.

The notification below, which has been made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Claire-Marie O’Grady

Company Secretary

5 October 2018

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of PDMR / person closely associated with them (“PCA”)
a) Name Nick Hampton
2. Reason for the notification
a) Position / status PDMR
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Acquisition of shares following the exercise of nil-cost options over shares for no consideration.
c) Price(s) and volume(s)

Price(s) Volume(s)

Nil 143,428

d)

Aggregated information

- Aggregated volume

- Price

143,428

Nil

e) Date of the transaction 2018-10-04
f) Place of the transaction Outside a trading venue

View source version on businesswire.com: https://www.businesswire.com/news/home/20181005005259/en/

Copyright Business Wire 2018

Date   Source Headline
12th Jan 202610:00 amRNSHolding(s) in Company
7th Jan 20264:30 pmRNSDirector/PDMR Shareholding
7th Jan 20262:30 pmRNSBlock listing Interim Review
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
11th Dec 202512:18 pmRNSDirector/PDMR Shareholding
9th Dec 20259:00 amRNSHolding(s) in Company
27th Nov 202510:00 amRNSDirector/PDMR Shareholding
11th Nov 20254:30 pmRNSDirector/PDMR Shareholding
10th Nov 20252:40 pmRNSDirector Declaration
6th Nov 20257:00 amRNSHalf-year Financial Report
5th Nov 20252:15 pmRNSHolding(s) in Company
3rd Nov 20255:00 pmRNSHolding(s) in Company
29th Oct 20252:00 pmRNSHolding(s) in Company
23rd Oct 20254:15 pmRNSHolding(s) in Company
21st Oct 20253:30 pmRNSHolding(s) in Company
16th Oct 202512:00 pmRNSHolding(s) in Company
8th Oct 202512:00 pmRNSHolding(s) in Company
6th Oct 20254:30 pmRNSDirector/PDMR Shareholding
6th Oct 20254:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
3rd Oct 202510:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSPre-close statement
2nd Sep 20258:00 amRNSTotal Voting Rights
11th Aug 20251:00 pmRNSDirector/PDMR Shareholding
5th Aug 20257:00 amRNSDirector/PDMR Shareholding
1st Aug 202511:00 amRNSTotal Voting Rights
24th Jul 20252:30 pmRNSResult of Annual General Meeting 2025
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
1st Jul 20253:30 pmRNSBlock listing Interim Review
1st Jul 20257:00 amRNSTate & Lyle Capital Markets Event
13th Jun 20253:00 pmRNSHolding(s) in Company
11th Jun 20254:30 pmRNSDirector/PDMR Shareholding
5th Jun 20252:30 pmRNSAnnual Financial Report and Notice of Meeting 2025
5th Jun 20252:00 pmRNSDirector/PDMR Shareholding
2nd Jun 202512:30 pmRNSTotal Voting Rights
28th May 202512:00 pmRNSDirector/PDMR Shareholding
27th May 202512:00 pmRNSDirector/PDMR Shareholding
23rd May 202510:00 amRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSFinal Results
14th May 20259:00 amRNSHolding(s) in Company
1st May 20253:00 pmRNSHolding(s) in Company
29th Apr 20253:30 pmRNSHolding(s) in Company
28th Apr 20255:15 pmRNSHolding(s) in Company
24th Apr 202512:00 pmRNSHolding(s) in Company
15th Apr 20257:00 amRNSIntegration update and pre-close statement
27th Mar 20257:00 amRNSDirectorate Change
14th Mar 202510:05 amRNSDirectorate declaration
11th Mar 20253:00 pmRNSHolding(s) in Company
5th Mar 202511:30 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.